NewLimit has raised an additional 45M in funding from @EliLillyandCo, Duke, @S32_VC, and others to develop longevity medicines. This latest round is driven by progress since our series B 5 months ago. Thank you to these new backers for helping our efforts to improve the lives of everyone on the planet. Follow @newlimit for more and see blog post with more details in thread below 👇(Brian Armstrong)